Logo
x

Search

Subscribe Now

Biophytis

Biophytis Reports the US FDA’s IND Clearance to Initiate the P-II Trial of BIO101 for Treating Obesity

Biophytis Reports the US FDA’s IND Clearance to Initiate the P-II Trial of BIO101 for Treating Obesity

  • July 11, 2024
Biophytis and Blanver Collaborate to Develop BIO101 for Treating Multiple Indications

Biophytis and Blanver Collaborate to Develop BIO101 for Treating Multiple Indications

  • June 20, 2024
Insights+: COVID-19 Healthcare News Monthly Updates - October 2020

Insights+: COVID-19 Healthcare News Monthly Updates - October 2020

  • October 30, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.